dertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.Contact:ICR, LLCChristine Duan or Ashley Ammon203-682-8200AMERICAN ORIENTAL BIOENGINEERING, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME(UNAUDITED)THREE MONTHS ENDED
JUNE 30SIX MONTHS ENDEDJUNE 302011201020112010Revenues$54,051,796
$77,296,212
$106,053,906
$131,045,980Cost of sales28,206,94537,455,86055,133,14562,968,907GROSS PROFIT25,844,85139,840,35250,920,76168,077,073Selling, general & administrative expenses11,258,09816,663,56622,497,34527,406,278Advertising costs3,399,3559,217,2477,220,50315,965,717Research and development costs3,125,2763,250,8825,826,4886,029,691Depreciation and amortization 1,784,3801,622,9893,555,0913,219,947Total operating expenses 19,567,10930,754,68439,099,42752,621,633INCOME FROM OPERATIONS6,277,7429,085,66811,821,33415,455,440Equity in earnings (losses) from unconsolidated entities551,461(296,301)141,575(41,086)Gain (loss) on changes in ownership of unconsolidated entities1,417,878125,5021,417,878(12,240)Interest expense, net(1,518,810)(1,371,246)(3,032,395)(2,937,031)Other income (expenses), net11,887(30,039)437,767(17,792)INCOME BEFORE INCOME TAXES6,740,1587,513,58410,786,15912,447,291Income tax3,169,8132,395,8506,294,6684,211,780NET INCOME3,570,3455,117,7344,491,4918,235,511Net loss attribute to non-controlling interest10,6736,47613,67911,876NET INCOME ATTRIBUTABLE TO CONTROLLING INTEREST3,581,0185,124,2104,505,1708,247,387OTHER COMPREHENSIVE INCOME8,277,8111,843,65411,410,2771,936,503COMPREHENSIVE INCOME$11,858,829
$6,967,864
$15,915,447
$10,183,890EARNINGS PER COMMON SHAREBasic$0.05
$0.07
$0.06
$0.11Diluted$0.05
$0.07
$0.06
$0.11WEIGHTED AVERAGE SHARES OUTSTANDINGBasic74,675,13674,743,98674,788,6337
'/>"/>
SOURCE American Oriental Bioengineering, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine technology :1.
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems2.
American Pacific to Release Financial Results and Hold Fiscal 2011 Third Quarter Investor Teleconference3.
American Regent, Inc. Initiates Voluntary Recall of Seventeen Lots of Vasopressin Injection, USP, Multiple Dose Vials due to Sub-Potency4.
Grifols Announces New North American Commercial Operations Organization5.
Siemens Partners with American Cancer Society to Make Strides Against Breast Cancer6.
Stigma Remains a Significant Barrier to Routine HIV Testing by African-American Physicians, Survey Finds7.
Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels8.
Survey Finds More Than One in Three Americans Have Been Personally Affected By Infections Resulting From a Hospital Stay9.
Waters Showcases ACQUITY UltraPerformance LC and Mass Spectrometry (UPLC/MS) Tools for Increasing Laboratory Efficiency at the American Association for Clinical Chemistry Annual Meeting10.
North American External Defibrillator Market11.
American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program